These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11817524)

  • 21. Whole blood coagulation analyzers.
    Health Devices; 1997 Aug; 26(8):296-332. PubMed ID: 9283920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two methods for heparin monitoring: a semi-automated heparin monitoring device and activated clotting time during extracorporeal circulation.
    Stead SW
    Int J Clin Monit Comput; 1989 Dec; 6(4):247-54. PubMed ID: 2628513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
    Krajewski S; Krauss S; Kurz J; Neumann B; Schlensak C; Wendel HP
    Thromb Res; 2014 Mar; 133(3):455-63. PubMed ID: 24359968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass.
    Gruenwald C; de Souza V; Chan AK; Andrew M
    Perfusion; 2000 Jun; 15(3):203-9. PubMed ID: 10866421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of tests for heparin control during long-term extracorporeal circulation.
    Uziel L; Cugno M; Cacciabue E; Colombo A; Stabilini R; Mascheroni D; Agostoni A
    Int J Artif Organs; 1986 Mar; 9(2):111-6. PubMed ID: 3699906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Point-of-Care ACT Coagulometers and Anti-Xa Activity During Cardiopulmonary Bypass.
    Falter F; MacDonald S; Matthews C; Kemna E; Cañameres J; Besser M
    J Cardiothorac Vasc Anesth; 2020 Nov; 34(11):2921-2927. PubMed ID: 32620484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboprophylaxis With Heparin During Orthotopic Liver Transplantation: Comparison of Hepcon HMS Plus and Anti-Xa Assays for Low-Range Heparin.
    Nicolau-Raducu R; Occhipinti E; Marshall T; Koveleskie J; Ganier D; Evans B; Daly W; Fish B; Cohen AJ; Reichman TW; Bruce D; Bohorquez H; Seal J; Ahmed E; Carmody I; Loss G; Rayburn J; Nossaman B
    J Cardiothorac Vasc Anesth; 2017 Apr; 31(2):575-581. PubMed ID: 27745797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a bedside device to assess the activated partial thromboplastin time for heparin monitoring in infants.
    Klein RH; van der Vorst MM; de Wilde RB; Hogenbirk K; de Kam ML; Burggraaf J
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):327-31. PubMed ID: 23337708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of five point-of-care prothrombin and activated partial thromboplastin time devices based on age of blood sample.
    Searles B; Nasrallah F; Graham S; Lajara RB
    J Extra Corpor Technol; 2002 Sep; 34(3):178-81. PubMed ID: 12395962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of point-of-care activated clotting time systems utilized in a single pediatric institution.
    Ojito JW; Hannan RL; Burgos MM; Lim H; Huynh M; Velis E; Arocha M; Tirotta CF; Burke RP
    J Extra Corpor Technol; 2012 Mar; 44(1):15-20. PubMed ID: 22730859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels.
    Saw J; Kereiakes DJ; Mahaffey KW; Applegate RJ; Braden GA; Brent BN; Brodie BR; Groce JB; Levine GN; Leya F; Moliterno DJ
    Thromb Res; 2003; 112(5-6):301-6. PubMed ID: 15041274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Difference in examination of coagulation function in heparin anticoagulant therapy between point of care tests and automatic coagulation analyzer].
    Li J; Cong YL; Tu GH; Yang L; Zhu BB; Jin L
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1269-71. PubMed ID: 17686264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
    El Rouby S; Rinehart K; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical evaluation of heparin concentration and activated clotting time monitoring (HEPCON HMS) system].
    Sakurada T; Kikuchi Y; Koushima R; Nakashima S; Hachiro Y; Kagaya H
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun; 45(6):836-40. PubMed ID: 9217380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgery.
    Niles SD; Sutton RG; Ploessl J; Pennell B
    J Extra Corpor Technol; 1995 Dec; 27(4):197-200. PubMed ID: 10172651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of a microsample coagulation analyzer, and comparison with existing techniques.
    Carter AJ; Hicks K; Heldman AW; Resar JR; Laird JR; Coombs VJ; Brinker JA; Blumenthal RS
    Cathet Cardiovasc Diagn; 1996 Sep; 39(1):97-102. PubMed ID: 8874958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.